Literature DB >> 8082908

Tumours of the liver.

C H Frith1, J M Ward, V S Turusov.   

Abstract

Mesh：

Year:  1994        PMID： 8082908

Source DB:  PubMed          Journal:  IARC Sci Publ        ISSN： 0300-5038


× No keyword cloud information.
  24 in total

1.  Differential requirement for de novo lipogenesis in cholangiocarcinoma and hepatocellular carcinoma of mice and humans.

Authors:  Lei Li; Li Che; Kevin M Tharp; Hyo-Min Park; Maria G Pilo; Dan Cao; Antonio Cigliano; Gavinella Latte; Zhong Xu; Silvia Ribback; Frank Dombrowski; Matthias Evert; Gregory J Gores; Andreas Stahl; Diego F Calvisi; Xin Chen
Journal:  Hepatology       Date:  2016-03-25       Impact factor: 17.425

2.  Proceedings of the 2009 National Toxicology Program Satellite Symposium.

Authors:  Ute Bach; James R Hailey; Georgette D Hill; Wolfgang Kaufmann; Kenneth S Latimer; David E Malarkey; Robert M Maronpot; Rodney A Miller; Rebecca R Moore; James P Morrison; Thomas Nolte; Matthias Rinke; Susanne Rittinghausen; Andrew W Suttie; Gregory S Travlos; John L Vahle; Gabrielle A Willson; Susan A Elmore
Journal:  Toxicol Pathol       Date:  2009-12-15       Impact factor: 1.902

3.  Vitamin E reduces chromosomal damage and inhibits hepatic tumor formation in a transgenic mouse model.

Authors:  V M Factor; D Laskowska; M R Jensen; J T Woitach; N C Popescu; S S Thorgeirsson
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-29       Impact factor: 11.205

4.  Synergistic role of Sprouty2 inactivation and c-Met up-regulation in mouse and human hepatocarcinogenesis.

Authors:  Susie A Lee; Sara Ladu; Matthias Evert; Frank Dombrowski; Valentina De Murtas; Xin Chen; Diego F Calvisi
Journal:  Hepatology       Date:  2010-08       Impact factor: 17.425

5.  Inactivation of Spry2 accelerates AKT-driven hepatocarcinogenesis via activation of MAPK and PKM2 pathways.

Authors:  Chunmei Wang; Salvatore Delogu; Coral Ho; Susie A Lee; Bing Gui; Lijie Jiang; Sara Ladu; Antonio Cigliano; Frank Dombrowski; Matthias Evert; Diego F Calvisi; Xin Chen
Journal:  J Hepatol       Date:  2012-05-19       Impact factor: 25.083

6.  Activated mutant forms of PIK3CA cooperate with RasV12 or c-Met to induce liver tumour formation in mice via AKT2/mTORC1 cascade.

Authors:  Chunmei Wang; Li Che; Junjie Hu; Shanshan Zhang; Lijie Jiang; Gavinella Latte; Maria I Demartis; Junyan Tao; Bing Gui; Maria G Pilo; Silvia Ribback; Frank Dombrowski; Matthias Evert; Diego F Calvisi; Xin Chen
Journal:  Liver Int       Date:  2016-01-30       Impact factor: 5.828

7.  Spontaneous hepatocarcinogenesis in farnesoid X receptor-null mice.

Authors:  Insook Kim; Keiichirou Morimura; Yatrik Shah; Qian Yang; Jerrold M Ward; Frank J Gonzalez
Journal:  Carcinogenesis       Date:  2006-12-20       Impact factor: 4.944

8.  Assessing the potential for AAV vector genotoxicity in a murine model.

Authors:  Hojun Li; Nirav Malani; Shari R Hamilton; Alexander Schlachterman; Giulio Bussadori; Shyrie E Edmonson; Rachel Shah; Valder R Arruda; Federico Mingozzi; J Fraser Wright; Frederic D Bushman; Katherine A High
Journal:  Blood       Date:  2010-11-24       Impact factor: 22.113

9.  AKT (v-akt murine thymoma viral oncogene homolog 1) and N-Ras (neuroblastoma ras viral oncogene homolog) coactivation in the mouse liver promotes rapid carcinogenesis by way of mTOR (mammalian target of rapamycin complex 1), FOXM1 (forkhead box M1)/SKP2, and c-Myc pathways.

Authors:  Coral Ho; Chunmei Wang; Sandra Mattu; Giulia Destefanis; Sara Ladu; Salvatore Delogu; Julia Armbruster; Lingling Fan; Susie A Lee; Lijie Jiang; Frank Dombrowski; Matthias Evert; Xin Chen; Diego F Calvisi
Journal:  Hepatology       Date:  2011-12-19       Impact factor: 17.425

10.  Hippo Cascade Controls Lineage Commitment of Liver Tumors in Mice and Humans.

Authors:  Shanshan Zhang; Jingxiao Wang; Haichuan Wang; Lingling Fan; Biao Fan; Billy Zeng; Junyan Tao; Xiaolei Li; Li Che; Antonio Cigliano; Silvia Ribback; Frank Dombrowski; Bin Chen; Wenming Cong; Lixin Wei; Diego F Calvisi; Xin Chen
Journal:  Am J Pathol       Date:  2018-01-31       Impact factor: 4.307
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.